Ernst U. Frevert

Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome

Barbara L. Cool, Bradley A. Zinker, William J. Chiou et al. · Cell Metabolism · 2006 · 918 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Regulation of Early Events in Integrin Signaling by Protein Tyrosine Phosphatase SHP-2

Eok‐Soo Oh, Haihua Gu, Tracy M. Saxton et al. · Molecular and Cellular Biology · 1999 · 211 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Differential Effects of Constitutively Active Phosphatidylinositol 3-Kinase on Glucose Transport, Glycogen Synthase Activity, and DNA Synthesis in 3T3-L1 Adipocytes

Ernst U. Frevert, Barbara B. Kahn · Molecular and Cellular Biology · 1997 · 178 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

Overexpression of Protein-tyrosine Phosphatase-1B in Adipocytes Inhibits Insulin-stimulated Phosphoinositide 3-Kinase Activity without Altering Glucose Transport or Akt/Protein Kinase B Activation

Carol L. Venable, Ernst U. Frevert, Young‐Bum Kim et al. · Journal of Biological Chemistry · 2000 · 114 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

David W. Boulton, Li Li, Ernst U. Frevert et al. · Clinical Pharmacokinetics · 2011 · 108 citations

Pharmacy, Pharmacokinetics, Pharmacology +12